counter
Intervet Fish
To the Intervet Website
Contact
International Products
Home
Intervet - Research makes the difference Featured Products
Gonazon™ for fish
For induction & synchronization of ovulation for the production of eyed-eggs & fry.
Compact™ Fur-IPN
Vaccine against furunculosis and infectious pancreatic necrosis (IPN) in Atlantic salmon.
Norvax® Strep Si
Vaccine against streptococcal disease in susceptible fish species like Asian seabass.
Norvax® Compact 4
Vaccine against furunculosis, classical vibriosis and coldwater vibriosis in Atlantic salmon.
Norvax® Compact 6
Vaccine against furunculosis, classical vibriosis, coldwater vibriosis, wound disease and infectious pancreatic necrosis (IPN) in Atlantic salmon.
Norvax® Minova 4WD
Vaccine against furunculosis, coldwater vibriosis, vibriosis and wound disease in Atlantic salmon.
Innovative CD on "Fish Vaccination and Health Management in Asia"
Fish Vaccination and Health Management in Asia CD
Norvax® Vibriose (Mediterranean)
Vaccine against vibriosis in sea bass and sea bream.
Norvax® Vibriose (Salmonids)
Vaccine against vibriosis in Atlantic salmon and rainbow trout.
Norvax® Vibriose Marine
Vaccine against classical vibriosis in Atlantic cod.
Norvax® Vibrio mono
Vaccine against vibriosis in yellowtail.
Norvax® FurVib
Vaccine against furunculosis and classical vibriosis in Atlantic salmon and rainbow trout.
Norvax® Minova 6
Vaccine against furunculosis, classical vibriosis, coldwater vibriosis, wound disease and infectious pancreatic necrosis (IPN) in Atlantic salmon.
Norvax® Compact PD
Vaccine against Pancreas Disease in Atlantic salmon.
Compact™ IPN
Vaccine against infectious pancreatic necrosis (IPN) in salmonid fish.
Compact™ Vib-IPN
Vaccine against vibriosis and infectious pancreatic necrosis (IPN) in Atlantic salmon.
Chorulon®
For use as an aid in improving spawning function in male and female brood finfish.


Norvax® Minova 4WD - Product Overview
Coming Soon
Norvax® Minova 4WD is an inactivated vaccine against furunculosis, coldwater vibriosis, vibriosis and wound disease for intraperitoneal injection in Atlantic salmon.
Norvax® Minova 4WD - Product Data Sheet

Product class Vaccines
Target species Fish (Atlantic salmon; Salmo salar)
Description Inactivated vaccine against furunculosis, coldwater vibriosis, vibriosis and wound disease for intraperitoneal injection in Atlantic salmon.
Composition Inactivated strains of Listonella (Vibrio) anguillarum serovar O1, Listonella (Vibrio) anguillarum serovar O2α, Aeromonas salmonicida subsp. salmonicida, Vibrio salmonicida and Moritella viscosa.
Formulation Emulsion for injection.
Indications For active immunization of Atlantic salmon to reduce mortality due to the diseases furunculosis caused by Aeromonas salmonicida subsp. salmonicida, vibriosis caused by Listonella (Vibrio) anguillarum serovar O1 and/or Listonella (Vibrio) anguillarum serovar O2α, coldwater vibriosis caused by Vibrio salmonicida and wound disease caused by Moritella viscosa.
Dosage Inject 0.1 ml intraperitoneally along the central line, 1 - 1.5 fin lengths in front of the pelvic fin base. Ensure the recommended dose is deposited into the abdominal cavity before the needle is withdrawn. The length and diameter of the needle should be adapted to the actual fish size.
Withholding period Nil. (National regulations should be observed).
Presentation Norvax® Minova 4WD is available in 500-ml PET bottles.
Storage Store and transport between 2 and 8°C. Do not freeze. Opened bottles should be used within 4 hours. Don't use after the expiry date.
Contra-indications None
Further information Vaccination is recommended for fish at or above 35 grams. The water temperature at vaccination should be at or below 15°C. Fish should be withheld from feed for 1-2 days before vaccination. Fish should be anaesthetised according to veterinary recommendations. Start feeding, at the earliest, 12 hours after vaccination. Only healthy fish should be vaccinated. Do not use in breeding stock. No information is available on the safety and efficacy from the concurrent use of this vaccine with any other. It is therefore recommended that no other vaccines should be administered within 14 days before or after vaccination with this product. Shake well before use. Sterile injection equipment should be used. At least 500 degree days are recommended from vaccination to potential exposure to furunculosis, vibriosis, coldwater vibriosis and wound disease.
Undesirable effects When undesirable effects occur, they are normally seen in the abdominal cavity. Vaccinated animals normally show very slight to moderate adhesions between viscera or between viscera and the abdominal wall. The eventual adhesions may be removed manually and are thus not severe. Occasionally, vaccinated populations may show adhesions between greater parts of the abdominal organs, granulomas and/or more massive pigmentation. Such lesions are typically seen in < 10% of the treated animals.


GENERAL REMINDER:
Usage instructions & withdrawal periods may vary by Country.
Always follow label instructions and consult your veterinarian.

Who's Online?

Sunday 22nd November

Search Site
Books and Photos
Book Shop Stock Photography